Plain-English translation of NCT06717334 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is testing whether unexplained weight loss is a warning sign that someone might develop lung cancer, and whether blood tests can help detect lung cancer earlier. All participants will receive annual low-dose CT scans of the lungs—a type of imaging that uses very small amounts of radiation to take detailed pictures—and will have blood samples collected to look for cancer markers.
Lung cancer is often found late, when it's harder to treat. Researchers want to understand if unexplained weight loss could be an early warning sign that helps catch lung cancer sooner, when treatment is more likely to work.
You likely qualify if…
You likely don't qualify if…
You will come in for an annual low-dose CT scan of your lungs, which takes just a few minutes. At your first visit and again at one year, you'll also have blood samples drawn so researchers can analyze them for cancer markers. The study involves standard medical imaging and blood work—no medications or invasive procedures—and you'll receive results like you would with regular health screening.
AI-generated summary from trial data · Aug 8, 2026 · Not medical advice
United States